tetano
Editor, Senior Moderator
Eur J Clin Microbiol Infect Dis. 2016 Aug 4. [Epub ahead of print]
[h=1]IFITM3 and severe influenza virus infection. No evidence of genetic association.[/h] L?pez-Rodr?guez M[SUP]1,[/SUP][SUP]2[/SUP], Herrera-Ramos E[SUP]1,[/SUP][SUP]3[/SUP], Sol?-Viol?n J[SUP]4[/SUP], Ru?z-Hern?ndez JJ[SUP]5[/SUP], Border?as L[SUP]6[/SUP], Horcajada JP[SUP]7,[/SUP][SUP]8[/SUP], Lerma-Chippirraz E[SUP]7[/SUP], Rajas O[SUP]9[/SUP], Briones M[SUP]10[/SUP], P?rez-Gonz?lez MC[SUP]11[/SUP], Garc?a-Bello MA[SUP]12[/SUP], L?pez-Granados E[SUP]13[/SUP], Rodriguez de Castro F[SUP]3,[/SUP][SUP]14[/SUP], Rodr?guez-Gallego C[SUP]15,[/SUP][SUP]16[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza virus infection (IVI) is typically subclinical or causes a self-limiting upper respiratory disease. However, in a small subset of patients IVI rapidly progresses to primary viral pneumonia (PVP) with respiratory failure; a minority of patients require intensive care unit admission. Inherited and acquired variability in host immune responses may influence susceptibility and outcome of IVI. However, the molecular basis of such human factors remains largely elusive. It has been proposed that homozygosity for IFITM3 rs12252-C is associated with a population-attributable risk of 5.4 % for severe IVI in Northern Europeans and 54.3 % for severe H1N1pdm infection in Chinese. A total of 148 patients with confirmed IVI were considered for recruitment; 118 Spanish patients (60 of them hospitalized with PVP) and 246 healthy Spanish individuals were finally included in the statistical analysis. PCR-RFLP was used with confirmation by Sanger sequencing. The allele frequency for rs12252-C was found to be 3.5 % among the general Spanish population. We found no rs12252-C homozygous individuals in our control group. The only Spanish patient homozygous for rs12252-C had a neurological disorder (a known risk factor for severe IVI) and mild influenza. Our data do not suggest a role of rs12252-C in the development of severe IVI in our population. These data may be relevant to recognize whether patients homozygous for rs12252-C are at risk of severe influenza, and hence require individualized measures in the case of IVI.
PMID: 27492307 DOI: 10.1007/s10096-016-2732-7
[PubMed - as supplied by publisher]
[h=1]IFITM3 and severe influenza virus infection. No evidence of genetic association.[/h] L?pez-Rodr?guez M[SUP]1,[/SUP][SUP]2[/SUP], Herrera-Ramos E[SUP]1,[/SUP][SUP]3[/SUP], Sol?-Viol?n J[SUP]4[/SUP], Ru?z-Hern?ndez JJ[SUP]5[/SUP], Border?as L[SUP]6[/SUP], Horcajada JP[SUP]7,[/SUP][SUP]8[/SUP], Lerma-Chippirraz E[SUP]7[/SUP], Rajas O[SUP]9[/SUP], Briones M[SUP]10[/SUP], P?rez-Gonz?lez MC[SUP]11[/SUP], Garc?a-Bello MA[SUP]12[/SUP], L?pez-Granados E[SUP]13[/SUP], Rodriguez de Castro F[SUP]3,[/SUP][SUP]14[/SUP], Rodr?guez-Gallego C[SUP]15,[/SUP][SUP]16[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza virus infection (IVI) is typically subclinical or causes a self-limiting upper respiratory disease. However, in a small subset of patients IVI rapidly progresses to primary viral pneumonia (PVP) with respiratory failure; a minority of patients require intensive care unit admission. Inherited and acquired variability in host immune responses may influence susceptibility and outcome of IVI. However, the molecular basis of such human factors remains largely elusive. It has been proposed that homozygosity for IFITM3 rs12252-C is associated with a population-attributable risk of 5.4 % for severe IVI in Northern Europeans and 54.3 % for severe H1N1pdm infection in Chinese. A total of 148 patients with confirmed IVI were considered for recruitment; 118 Spanish patients (60 of them hospitalized with PVP) and 246 healthy Spanish individuals were finally included in the statistical analysis. PCR-RFLP was used with confirmation by Sanger sequencing. The allele frequency for rs12252-C was found to be 3.5 % among the general Spanish population. We found no rs12252-C homozygous individuals in our control group. The only Spanish patient homozygous for rs12252-C had a neurological disorder (a known risk factor for severe IVI) and mild influenza. Our data do not suggest a role of rs12252-C in the development of severe IVI in our population. These data may be relevant to recognize whether patients homozygous for rs12252-C are at risk of severe influenza, and hence require individualized measures in the case of IVI.
PMID: 27492307 DOI: 10.1007/s10096-016-2732-7
[PubMed - as supplied by publisher]